Analyst Expectations for Bristol-Myers Squibb's Future
Portfolio Pulse from Benzinga Insights
Over the past 3 months, 4 analysts have published their opinion on Bristol-Myers Squibb (NYSE:BMY) stock. The company has an average price target of $76.5 with a high of $85.00 and a low of $65.00. This average price target has increased by 1.55% over the past month.
June 28, 2023 | 3:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Analysts have a bullish outlook on Bristol-Myers Squibb (NYSE:BMY) with an average price target of $76.5, which has increased by 1.55% over the past month.
The bullish outlook from analysts indicates a positive sentiment towards Bristol-Myers Squibb. The increase in the average price target over the past month suggests that analysts are becoming more optimistic about the company's future performance, which could potentially lead to an increase in the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100